Search - tctmd.com

Displaying 221 - 240 of 356

Sort: Relevancy | Date

Presentation TCT 2015

Turkey Presents: A Case Assessing Microvascular Resistance in Non-STEMI

Presenter: Morton J. Kern, Jan J. Piek, Murat Sezer

October 12, 2015

Presentation TCT 2015

The Netherlands Presents: A Case Demonstration of Coronary Flow Capacity to Document Ischemic Heart Disease

Presenter: Morton J. Kern, Jan J. Piek, Tim P. van de Hoef

October 12, 2015

Presentation TCT 2015

Italy Presents: A Case Demonstrating the Diagnostic Workup in Nonobstructive Coronary Artery Disease

Presenter: Morton J. Kern, Jan J. Piek, Giampaolo Niccoli

October 12, 2015

Presentation TCT 2015

Spain Presents: A Case of iFR-FFR to Guide Coronary Revascularization in Multivessel Disease

Presenter: Morton J. Kern, Jan J. Piek, Javier Escaned

October 12, 2015

Presentation TCT 2015

The United Kingdom Presents: A Case of iFR for Evaluation of Serial Stenosis Using Pullback

Presenter: Morton J. Kern, Jan J. Piek, Justin E. Davies

October 12, 2015

News Conference News TCT 2015

Mortality Increasing in Elderly PCI Patients

October 12, 2015

Presentation TCT 2015

How to Assess the Quality of Evidence From Peer-Reviewed Manuscripts: The Statistical Reviewers Vantage Point

Presenter: Robert A. Harrington, Pascal Vranckx, Jan Tijssen

October 11, 2015

Presentation TCT 2015

Bayesian Statistics: Can They Be Trusted (or Understood)?!

Presenter: Stuart J. Pocock, Jan Tijssen, Sanjay Kaul

October 11, 2015

Presentation TCT 2015

Meta-analysis (Standard and Network): The Good, the Bad, and the Ugly

Presenter: Stuart J. Pocock, Jan Tijssen, Somjot S. Brar

October 11, 2015

Presentation TCT 2015

Composite Endpoints/Primary Endpoints/Weighted Endpoints/Patient-Reported Endpoints: How to Choose the Right Endpoint

Presenter: Stuart J. Pocock, Jan Tijssen

October 11, 2015

Presentation TCT 2015

Strategy Trials vs Device/Drug Comparisons: Important Considerations

Presenter: Stuart J. Pocock, Jan Tijssen, David J. Cohen

October 11, 2015

Presentation TCT 2015

Propensity-Matched Analysis: Advantages and Pitfalls (TRANSLATE and PROMETHEUS)

Presenter: Stuart J. Pocock, Jan Tijssen, Usman Baber

October 11, 2015

Presentation TCT 2015

Subgroup Analyses: How Useful or Harmful Are They?

Presenter: Stuart J. Pocock, Jan Tijssen, Darrel P. Francis

October 11, 2015

Presentation TCT 2015

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Presenter: Stuart J. Pocock, Jan Tijssen, John L. Petersen

October 11, 2015

News Conference News TCT 2014

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Todd Neale

October 10, 2014

News Conference News TCT 2014

Real-World Data Show Correlation Between Post-PCI Angina, Resource Utilization

September 18, 2014

Presentation TCT 2014

Will Bioresorbable Scaffolds Change How We Think About Left Main PCI?

Presenter: Andrejs Erglis, Nicholas J. Lembo, Hadley K. Wilson, Robert-Jan van Geuns

September 16, 2014

Presentation TCT 2014

Absorb III/IV: Testing Noninferiority and Superiority

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Dean J. Kereiakes

September 16, 2014

Presentation TCT 2014

Absorb III/IV: Angina and Ischemia Hypotheses

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Gregg W. Stone

September 16, 2014

Presentation TCT 2014

Update: The EXTEND Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Alexandre Abizaid

September 16, 2014

Advertisement

Turkey Presents: A Case Assessing Microvascular Resistance in Non-STEMI

The Netherlands Presents: A Case Demonstration of Coronary Flow Capacity to Document Ischemic Heart Disease

Italy Presents: A Case Demonstrating the Diagnostic Workup in Nonobstructive Coronary Artery Disease

Spain Presents: A Case of iFR-FFR to Guide Coronary Revascularization in Multivessel Disease

The United Kingdom Presents: A Case of iFR for Evaluation of Serial Stenosis Using Pullback

Mortality Increasing in Elderly PCI Patients

How to Assess the Quality of Evidence From Peer-Reviewed Manuscripts: The Statistical Reviewers Vantage Point

Bayesian Statistics: Can They Be Trusted (or Understood)?!

Meta-analysis (Standard and Network): The Good, the Bad, and the Ugly

Composite Endpoints/Primary Endpoints/Weighted Endpoints/Patient-Reported Endpoints: How to Choose the Right Endpoint

Strategy Trials vs Device/Drug Comparisons: Important Considerations

Propensity-Matched Analysis: Advantages and Pitfalls (TRANSLATE and PROMETHEUS)

Subgroup Analyses: How Useful or Harmful Are They?

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Real-World Data Show Correlation Between Post-PCI Angina, Resource Utilization

Will Bioresorbable Scaffolds Change How We Think About Left Main PCI?

Absorb III/IV: Testing Noninferiority and Superiority

Absorb III/IV: Angina and Ischemia Hypotheses

Update: The EXTEND Real-World Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content